Stock Events

Stock Events

Palatin Technologies 

$11.01
144
-$0.58-5% 20:00 Today

Statistics

Day High
11.6
Day Low
10.73
52W High
31
52W Low
5
Volume
11,572
Avg. Volume
17,514
Mkt Cap
19.59M
P/E Ratio
105.36
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2SepExpected
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.86
-0.49
1.89
4.26
Expected EPS
-1.2
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-34.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap201.93B
Amgen develops therapeutics in areas similar to Palatin, including reproductive health and cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap138.61B
Pfizer competes with Palatin in the development of novel drugs, including treatments in sexual health, where Palatin has a significant focus.
Lilly(Eli) &
LLY
Mkt Cap1.08T
Eli Lilly offers products in men's health and other areas that overlap with Palatin's focus, particularly in treatments for conditions like erectile dysfunction.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie, with its broad range of pharmaceutical products, competes in the same therapeutic areas as Palatin, including women's health and hormonal therapies.
Merck
MRK
Mkt Cap319.99B
Merck operates in various healthcare segments that compete with Palatin, including the development of drugs for sexual health and cardiovascular diseases.
Novartis
NVS
Mkt Cap305.1B
Novartis competes with Palatin in multiple areas, including cardiovascular and metabolic conditions, through its extensive research and development in these fields.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol Myers Squibb's diverse range of pharmaceutical products in areas like cardiovascular diseases places it in competition with Palatin Technologies.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline has a presence in the sexual health market, making it a competitor to Palatin, especially in the development of treatments for related conditions.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca's work in cardiovascular and metabolic diseases competes with Palatin's research and development efforts in similar therapeutic areas.

Holdings

About

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Show more...
CEO
Dr. Carl Spana Ph.D.
Employees
29
Country
United States
ISIN
US6960776010

Listings

STU
DE
PTN.STU
BATS
US
PTNT
LSE
GB
0KF3.LSE
XNAS
US
PTN

0 Comments

Share your thoughts

FAQ

What is Palatin Technologies stock price today?▼
The current price of PTN is $11.01 USD — it has decreased by -5% in the past 24 hours. Watch Palatin Technologies stock price performance more closely on the chart.
What is Palatin Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Palatin Technologies stocks are traded under the ticker PTN.
What is Palatin Technologies market cap?▼
Today Palatin Technologies has the market capitalization of 19.59M
When is the next Palatin Technologies earnings date?▼
Palatin Technologies is going to release the next earnings report on September 02, 2026.
What were Palatin Technologies earnings last quarter?▼
PTN earnings for the last quarter are -0.37 USD per share, whereas the estimation was -1.24 USD resulting in a +70.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Palatin Technologies revenue for the last year?▼
Palatin Technologies revenue for the last year amounts to 0 USD.
What is Palatin Technologies net income for the last year?▼
PTN net income for the last year is -34.61M USD.
How many employees does Palatin Technologies have?▼
As of July 06, 2026, the company has 29 employees.
In which sector is Palatin Technologies located?▼
Palatin Technologies operates in the Health & Wellness sector.
When did Palatin Technologies complete a stock split?▼
The last stock split for Palatin Technologies was on August 31, 2022 with a ratio of 1:25.
Where is Palatin Technologies headquartered?▼
Palatin Technologies is headquartered in Monmouth Junction, United States.